Molecular mechanisms of regeneration in Alzheimer's disease brain

Geriatrics and Gerontology International

Volumn 10, Issue SUPPL. 1, 2010, Pages

  Uchida, Yoko ^a  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

amyloid; Alzheimer's disease; Embryonic gene expression; Neurogenesis; Regeneration; Sprouting

Indexed keywords

AMYLOID BETA PROTEIN; GROWTH INHIBITOR; METALLOTHIONEIN III; MICROTUBULE ASSOCIATED PROTEIN 1; ASCL1 PROTEIN, HUMAN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; MICROTUBULE ASSOCIATED PROTEIN; MICROTUBULE-ASSOCIATED PROTEIN 1B; NERVE PROTEIN; OLIG2 PROTEIN, HUMAN;

ALZHEIMER DISEASE; BRAIN; CELL CULTURE; CELL DEATH; CELL DIFFERENTIATION; CELL REGENERATION; CENTRAL NERVOUS SYSTEM; DISEASE COURSE; GENE EXPRESSION; HUMAN; IMMUNOREACTIVITY; MICROENVIRONMENT; NEOCORTEX; NERVE CELL CULTURE; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NERVOUS SYSTEM DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; REGENERATIVE ABILITY; REVIEW; STEM CELL; ANIMAL; APOPTOSIS; DOWN REGULATION; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REGENERATION;

ALZHEIMER DISEASE; ANIMALS; APOPTOSIS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BRAIN; CELL DEATH; DOWN-REGULATION; GROWTH INHIBITORS; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; NERVE TISSUE PROTEINS; NEURONS; REGENERATION;

EID: 77954685035     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/j.1447-0594.2010.00607.x     Document Type: Review

References (74)

1. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci 1997, 20:154-159.
2. Wisniewski KE, Wisniewski HM, Wen GY. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol 1985, 17:278-282.
3. Armstrong RA. beta-Amyloid (A beta) deposition in elderly non-demented patients and patients with Alzheimer's disease. Neurosci Lett 1994, 178:59-62.
4. Giannakopoulos P, Hof PR, Mottier S, Michel JP, Bouras C. Neuropathological changes in the cerebral cortex of 1258 cases from a geriatric hospital: retrospective clinicopathological evaluation of a 10-year autopsy population. Acta Neuropathol (Berl) 1994, 87:456-468.
5. Yamaguchi H, Sugihara S, Ogawa A, Oshima N, Ihara Y. Alzheimer beta amyloid deposition enhanced by apoE epsilon4 gene precedes neurofibrillary pathology in the frontal association cortex of nondemented senior subjects. J Neuropathol Exp Neurol 2001, 60:731-739.
6. Irizarry MC, McNamara M, Fedorchak K, Hsiao K, Hyman BT. APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1. J Neuropathol Exp Neurol 1997, 56:965-973.
7. Irizarry MC, Soriano F, McNamara M. Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J Neurosci 1997, 17:7053-7059.
8. Oddo S, Caccamo A, Shepherd JD. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003, 39:409-421.
9. Arendt T. Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization. Neuroscience 2001, 102:723-765.
10. Jin K, Peel AL, Mao XO. Increased hippocampal neurogenesis in Alzheimer's disease. Proc Natl Acad Sci USA 2004, 101:343-347.
11. Phinney AL, Deller T, Stalder M. Cerebral amyloid induces aberrant axonal sprouting and ectopic terminal formation in amyloid precursor protein transgenic mice. J Neurosci 1999, 19:8552-8559.
12. Lopez-Toledano MA, Shelanski ML. Neurogenic effect of beta-amyloid peptide in the development of neural stem cells. J Neurosci 2004, 24:5439-5444.
13. Uchida Y, Takio K, Titani K, Ihara Y, Tomonaga M. The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein. Neuron 1991, 7:337-347.
14. Sewell AK, Jensen LT, Erickson JC, Palmiter RD, Winge DR. Bioactivity of metallothionein-3 correlates with its novel beta domain sequence rather than metal binding properties. Biochemistry 1995, 34:4740-4747.
15. Uchida Y, Ihara Y. The N-terminal portion of growth inhibitory factor is sufficient for biological activity. J Biol Chem 1995, 270:3365-3369.
16. Uchida Y, Gomi F, Masumizu T, Miura Y. Growth inhibitory factor prevents neurite extension and the death of cortical neurons caused by high oxygen exposure through hydroxyl radical scavenging. J Biol Chem 2002, 277:32353-32359.
17. Meloni G, Faller P, Vasak M. Redox silencing of copper in metal-linked neurodegenerative disorders: reaction of Zn7metallothionein-3 with Cu2+ ions. J Biol Chem 2007, 282:16068-16078.
18. Sakamoto T, Kawazoe Y, Uchida Y, Hozumi I, Inuzuka T, Watabe K. Growth inhibitory factor prevents degeneration of injured adult rat motoneurons. Neuroreport 2003, 14:2147-2151.
19. Kobayashi H, Uchida Y, Ihara Y. Molecular cloning of rat growth inhibitory factor cDNA and the expression in the central nervous system. Brain Res Mol Brain Res 1993, 19:188-194.
20. Tsuji S, Kobayashi H, Uchida Y, Ihara Y, Miyatake T. Molecular cloning of human growth inhibitory factor cDNA and its down-regulation in Alzheimer's disease. Embo J 1992, 11:4843-4850.
21. Adlard PA, West AK, Vickers JC. Increased density of metallothionein I/II-immunopositive cortical glial cells in the early stages of Alzheimer's disease. Neurobiol Dis 1998, 5:349-356.
22. Duguid JR, Bohmont CW, Liu NG, Tourtellotte WW. Changes in brain gene expression shared by scrapie and Alzheimer disease. Proc Natl Acad Sci USA 1989, 86:7260-7264.
23. Zambenedetti P, Giordano R, Zatta P. Metallothioneins are highly expressed in astrocytes and microcapillaries in Alzheimer's disease. J Chem Neuroanat 1998, 15:21-26.
24. Hozumi I, Asanuma M, Yamada M, Uchida Y. Metallothioneins and neurodegenerative diseases. J Health Sci 2004, 50:323-331.
25. Kawashima T, Doh-ura K, Uchida Y. Differential expression of metallothioneins in human prion diseases. Dement Geriatr Cogn Disord 1999, 11:251-262.
26. Uchida Y. Regulation of growth inhibitory factor expression by epidermal growth factor and interleukin-1beta in cultured rat astrocytes. J Neurochem 1999, 73:1945-1953.
27. Arai Y, Uchida Y, Takashima S. Developmental immunohistochemistry of growth inhibitory factor in normal brains and brains of patients with Down syndrome. Pediatr Neurol 1997, 17:134-138.
28. Erickson JC, Hollopeter G, Thomas SA, Froelick GJ, Palmiter RD. Disruption of the metallothionein-III gene in mice: analysis of brain zinc, behavior, and neuron vulnerability to metals, aging, and seizures. J Neurosci 1997, 17:1271-1281.
29. Puttaparthi K, Gitomer WL, Krishnan U, Son M, Rajendran B, Elliott JL. Disease progression in a transgenic model of familial amyotrophic lateral sclerosis is dependent on both neuronal and non-neuronal zinc binding proteins. J Neurosci 2002, 22:8790-8796.
30. Garner CC, Garner A, Huber G, Kozak C, Matus A. Molecular cloning of microtubule-associated protein 1 (MAP1A) and microtubule-associated protein 5 (MAP1B): identification of distinct genes and their differential expression in developing brain. J Neurochem 1990, 55:146-154.
31. Safaei R, Fischer I. Cloning of a cDNA encoding MAP1B in rat brain: regulation of mRNA levels during development. J Neurochem 1989, 52:1871-1879.
32. Schoenfeld TA, McKerracher L, Obar R, Vallee RB. MAP 1A and MAP 1B are structurally related microtubule associated proteins with distinct developmental patterns in the CNS. J Neurosci 1989, 9:1712-1730.
33. Geddes JW, Lundgren K, Kim YK. Aberrant localization of MAP5 immunoreactivity in the hippocampal formation in Alzheimer's disease. J Neurosci Res 1991, 30:183-191.
34. Hasegawa M, Arai T, Ihara Y. Immunochemical evidence that fragments of phosphorylated MAP5 (MAP1B) are bound to neurofibrillary tangles in Alzheimer's disease. Neuron 1990, 4:909-918.
35. Takahashi H, Hirokawa K, Ando S, Obata K. Immunohistological study on brains of Alzheimer's disease using antibodies to fetal antigens, C-series gangliosides and microtubule-associated protein 5. Acta Neuropathol (Berl) 1991, 81:626-631.
36. Yoshida H, Watanabe A, Ihara Y. Collapsin response mediator protein-2 is associated with neurofibrillary tangles in Alzheimer's disease. J Biol Chem 1998, 273:9761-9768.
37. Uchida Y. Overexpression of full-length but not N-terminal truncated isoform of microtubule-associated protein (MAP) 1B accelerates apoptosis of cultured cortical neurons. J Biol Chem 2003, 278:366-371.
38. Kutschera W, Zauner W, Wiche G, Propst F. The mouse and rat MAP1B genes: genomic organization and alternative transcription. Genomics 1998, 49:430-436.
39. Gonzalez-Billault C, Demandt E, Wandosell F. Perinatal lethality of microtubule-associated protein 1B-deficient mice expressing alternative isoforms of the protein at low levels. Mol Cell Neurosci 2000, 16:408-421.
40. Goedert M, Spillantini MG, Davies SW. Filamentous nerve cell inclusions in neurodegenerative diseases. Curr Opin Neurobiol 1998, 8:619-632.
41. Ebneth A, Godemann R, Stamer K, Illenberger S, Trinczek B, Mandelkow E. Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease. J Cell Biol 1998, 143:777-794.
42. Donahue JE, Berzin TM, Rafii MS. Agrin in Alzheimer's disease: altered solubility and abnormal distribution within microvasculature and brain parenchyma. Proc Natl Acad Sci USA 1999, 96:6468-6472.
43. Hashimoto T, Wakabayashi T, Watanabe A. CLAC: a novel Alzheimer amyloid plaque component derived from a transmembrane precursor, CLAC-P/collagen type XXV. Embo J 2002, 21:1524-1534.
44. Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 1991, 541:163-166.
45. Snow AD, Mar H, Nochlin D. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Am J Pathol 1988, 133:456-463.
46. Jensen PH, Islam K, Kenney J, Nielsen MS, Power J, Gai WP. Microtubule-associated protein 1B is a component of cortical Lewy bodies and binds alpha-synuclein filaments. J Biol Chem 2000, 275:21500-21507.
47. Ding J, Liu JJ, Kowal AS. Microtubule-associated protein 1B: a neuronal binding partner for gigaxonin. J Cell Biol 2002, 158:427-433.
48. Chiang LW, Grenier JM, Ettwiller L. An orchestrated gene expression component of neuronal programmed cell death revealed by cDNA array analysis. Proc Natl Acad Sci USA 2001, 98:2814-2819.
49. Yuan J, Yankner BA. Caspase activity sows the seeds of neuronal death. Nat Cell Biol 1999, 1:E44-E45.
50. Nunes MC, Roy NS, Keyoung HM. Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nat Med 2003, 9:439-447.
51. Ming GL, Song H. Adult neurogenesis in the mammalian central nervous system. Annu Rev Neurosci 2005, 28:223-250.
52. Magavi SS, Leavitt BR, Macklis JD. Induction of neurogenesis in the neocortex of adult mice. Nature 2000, 405:951-955.
53. Becker M, Lavie V, Solomon B. Stimulation of endogenous neurogenesis by anti-EFRH immunization in a transgenic mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 2007, 104:1691-1696.
54. Dong H, Goico B, Martin M, Csernansky CA, Bertchume A, Csernansky JG. Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stress. Neuroscience 2004, 127:601-609.
55. Donovan MH, Yazdani U, Norris RD, Games D, German DC, Eisch AJ. Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease. J Comp Neurol 2006, 495:70-83.
56. Haughey NJ, Nath A, Chan SL, Borchard AC, Rao MS, Mattson MP. Disruption of neurogenesis by amyloid beta-peptide, and perturbed neural progenitor cell homeostasis, in models of Alzheimer's disease. J Neurochem 2002, 83:1509-1524.
57. Wang R, Dineley KT, Sweatt JD, Zheng H. Presenilin 1 familial Alzheimer's disease mutation leads to defective associative learning and impaired adult neurogenesis. Neuroscience 2004, 126:305-312.
58. Wen PH, Shao X, Shao Z, Hof PR. Overexpression of wild type but not an FAD mutant presenilin-1 promotes neurogenesis in the hippocampus of adult mice. Neurobiol Dis 2002, 10:8-19.
59. Jin K, Galvan V, Xie L. Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APPSw,Ind) mice. Proc Natl Acad Sci USA 2004, 101:13363-13367.
60. Calafiore M, Battaglia G, Zappala A. Progenitor cells from the adult mouse brain acquire a neuronal phenotype in response to beta-amyloid. Neurobiol Aging 2006, 27:606-613.
61. Mazur-Kolecka B, Golabek A, Nowicki K, Flory M, Frackowiak J. Amyloid-beta impairs development of neuronal progenitor cells by oxidative mechanisms. Neurobiol Aging 2006, 27:1181-1192.
62. Ross SE, Greenberg ME, Stiles CD. Basic helix-loop-helix factors in cortical development. Neuron 2003, 39:13-25.
63. Guillemot F, Joyner AL. Dynamic expression of the murine Achaete-Scute homologue Mash-1 in the developing nervous system. Mech Dev 1993, 42:171-185.
64. Nakatomi H, Kuriu T, Okabe S. Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell 2002, 110:429-441.
65. Elliott RC, Khademi S, Pleasure SJ, Parent JM, Lowenstein DH. Differential regulation of basic helix-loop-helix mRNAs in the dentate gyrus following status epilepticus. Neuroscience 2001, 106:79-88.
66. Furusho M, Ono K, Takebayashi H. Involvement of the Olig2 transcription factor in cholinergic neuron development of the basal forebrain. Dev Biol 2006, 293:348-357.
67. Hack MA, Saghatelyan A, de Chevigny A. Neuronal fate determinants of adult olfactory bulb neurogenesis. Nat Neurosci 2005, 8:865-872.
68. Yung SY, Gokhan S, Jurcsak J, Molero AE, Abrajano JJ, Mehler MF. Differential modulation of BMP signaling promotes the elaboration of cerebral cortical GABAergic neurons or oligodendrocytes from a common sonic hedgehog-responsive ventral forebrain progenitor species. Proc Natl Acad Sci U S A 2002, 99:16273-16278.
69. Zhou Q, Anderson DJ. The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification. Cell 2002, 109:61-73.
70. Hack MA, Sugimori M, Lundberg C, Nakafuku M, Gotz M. Regionalization and fate specification in neurospheres: the role of Olig2 and Pax6. Mol Cell Neurosci 2004, 25:664-678.
71. Ligon KL, Huillard E, Mehta S, Kesari S. Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma. Neuron 2007, 53:503-517.
72. Uchida Y, Nakano S, Gomi F, Takahashi H. Differential regulation of basic helix-loop-helix factors Mash1 and Olig2 by beta-amyloid accelerates both differentiation and death of cultured neural stem/progenitor cells. J Biol Chem 2007, 282:19700-19709.
73. Buffo A, Vosko MR, Erturk D. Expression pattern of the transcription factor Olig2 in response to brain injuries: implications for neuronal repair. Proc Natl Acad Sci USA 2005, 102:18183-18188.
74. Parras CM, Galli R, Britz O. Mash1 specifies neurons and oligodendrocytes in the postnatal brain. Embo J 2004, 23:4495-4505.